#NephMadness 2017: The Case for CRISPR-Cas9
The Finalists for NephMadness 2017 have been announced! Here, Dr. Freedman makes his case for CRISPR-Cas9: Benjamin Freedman Dr. Freedman, PhD, is Assistant Professor of [...]
Freedman
NephMadness 2015: APOL1, The Champion
Barry I. Freedman, MD, FACP is John H. Felts, III Distinguished Professor and Chief, Section on Nephrology at Wake Forest School of Medicine. His research focuses on [...]